相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome
Joseph Muenzer et al.
GENETICS IN MEDICINE (2011)
Idursulfase treatment of Hunter syndrome in children younger than 6 years: Results from the Hunter Outcome Survey
Joseph Muenzer et al.
GENETICS IN MEDICINE (2011)
Effects of enzyme replacement therapy on growth in patients with mucopolysaccharidosis type II
G. Schulze-Frenking et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2011)
A complete deficiency of Hyaluronoglucosaminidase 1 (HYAL1) presenting as familial juvenile idiopathic arthritis
Lisa Imundo et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2011)
Incidence and timing of infusion-related reactions in patients with mucopolysaccharidosis type II (Hunter syndrome) on idursulfase therapy in the real-world setting: A perspective from the Hunter Outcome Survey (HOS)
Barbara K. Burton et al.
MOLECULAR GENETICS AND METABOLISM (2011)
Mucopolysaccharidosis Type IIIA: Clinical Spectrum and Genotype-Phenotype Correlations
Marlies J. Valstar et al.
ANNALS OF NEUROLOGY (2010)
Brother/sister siblings affected with Hunter disease: evidence for skewed X chromosome inactivation
Kazuko Sukegawa et al.
CLINICAL GENETICS (2010)
Enzyme replacement therapy for mucopolysaccharidosis VI from 8 weeks of age-a sibling control study
J. J. McGill et al.
CLINICAL GENETICS (2010)
Importance of surgical history in diagnosing mucopolysaccharidosis type II (Hunter syndrome): Data from the Hunter Outcome Survey
Nancy J. Mendelsohn et al.
GENETICS IN MEDICINE (2010)
Mucopolysaccharidosis VI
Vassili Valayannopoulos et al.
ORPHANET JOURNAL OF RARE DISEASES (2010)
Transplant Outcomes in Mucopolysaccharidoses
Vinod K. Prasad et al.
SEMINARS IN HEMATOLOGY (2010)
Characterization of Surgical Procedures in Patients with Mucopolysaccharidosis Type I: Findings from the MPS I Registry
Pamela Arn et al.
JOURNAL OF PEDIATRICS (2009)
Long-term Efficacy and Safety of Laronidase in the Treatment of Mucopolysaccharidosis I
Lorne A. Clarke et al.
PEDIATRICS (2009)
Mucopolysaccharidosis I: Management and Treatment Guidelines
Joseph Muenzer et al.
PEDIATRICS (2009)
Intrathecal Enzyme Replacement Therapy in a Patient With Mucopolysaccharidosis Type I and Symptomatic Spinal Cord Compression
Maria-Veronica Munoz-Rojas et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2008)
The controversial and changing role of haematopoietic cell transplantation for lysosomal storage disorders: an update
A. M. Rovelli
BONE MARROW TRANSPLANTATION (2008)
Recognition and diagnosis of Mucopolysaccharidosis II (Hunter syndrome)
Rick Martin et al.
PEDIATRICS (2008)
Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failure
J. J. Boelens et al.
BONE MARROW TRANSPLANTATION (2007)
Enzyme replacement therapy in patients who have mucopolysaccharidosis I and are younger than 5 years:: Results of a multinational study of recombinant human α-L-iduronidase (Laronidase)
J. Edmond Wraith et al.
PEDIATRICS (2007)
A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)
Joseph Muenzer et al.
GENETICS IN MEDICINE (2006)
Newborn screening for lysosomal storage disorders
Peter J. Meikle et al.
MOLECULAR GENETICS AND METABOLISM (2006)
Enzyme replacement therapy for mucopolysaccharidosis VI: A Phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study
Paul Harmatz et al.
JOURNAL OF PEDIATRICS (2006)
Direct multiplex assay of enzymes in dried blood spots by tandem mass spectrometry for the newborn screening of lysosomal storage disorders
Michael H. Gelb et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2006)
Mucopolysaccharidoses and the eye
JL Ashworth et al.
SURVEY OF OPHTHALMOLOGY (2006)
Cumulative incidence rates of the mucopolysaccharidoses in Germany
F Baehner et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2005)
Threshold effect of urinary glycosaminoglycans and the walk test as indicators of disease progression in a survey of subjects with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)
SJ Swiedler et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2005)
Mucopolysaccharidosis type II in females: Case report and review of literature
K Tuschl et al.
PEDIATRIC NEUROLOGY (2005)
Clinical presentation and follow-up of patients with the attenuated phenotype of mucopolysaccharidosis type I
S Vijay et al.
ACTA PAEDIATRICA (2005)
Keratan sulphate levels in mucopolysaccharidoses and mucolipidoses
S Tomatsu et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2005)
Heparan sulfate levels in mucopolysaccharidoses and mucolipidoses
S Tomatsu et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2005)
Musculoskeletal manifestations of hurler syndrome - Long-term follow-up after bone marrow transplantation
JS Weisstein et al.
JOURNAL OF PEDIATRIC ORTHOPAEDICS (2004)
Usefulness of bone marrow transplantation in the Hurler syndrome
EA Braunlin et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Can mucopolysaccharidosis type I disease severity be predicted based on a patient's genotype? A comprehensive review of the literature
NJ Terlato et al.
GENETICS IN MEDICINE (2003)
Outcome of 27 patients with Hurler's syndrome transplanted from either related or unrelated haematopoietic stem cell sources
G Souillet et al.
BONE MARROW TRANSPLANTATION (2003)
Cardiac structural involvement in mucopolysaccharidoses
D Rigante et al.
CARDIOLOGY (2002)
Incidence of inborn errors of metabolism in British Columbia, 1969-1996
DA Applegarth et al.
PEDIATRICS (2000)
分享论文
